Search filters

List of works by Sandra M. Swain

3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).

scientific article published on 19 February 2017

3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3).

scientific article

8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer

scientific article published on January 1986

A Novel Case of Bisphosphonate-Related Osteonecrosis of the Torus Palatinus in a Patient with Metastatic Breast Cancer

scientific article published on 01 January 2006

A Passion for Solving the Puzzle of Cancer: Jane Cooke Wright, M.D., 1919-2013

A Phase II Trial with Trastuzumab and Pertuzumab in Patients with HER2-Overexpressed Locally Advanced and Metastatic Breast Cancer

Breast cancer trial article

A Step in the Right Direction

scientific article published on 23 May 2006

A critical review of the enrollment of black patients in cancer clinical trials

scientific article published on January 2012

A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer

scientific article published on 12 June 2007

A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer

scientific article published in October 2004

A phase II trial of paclitaxel (Taxol�) as first line treatment in advanced breast cancer

scientific article published on 01 January 1995

A pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials.

scientific article

A pilot study to evaluate the vascular endothelial growth factor receptor tyrosine kinase inhibitor AZD2171 and chemotherapy in locally advanced and inflammatory breast cancer

scientific article published in December 2005

A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up

scientific article published on 13 October 2006

ASCO's approach to a learning health care system in oncology.

scientific article published on May 2013

Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel

scientific article published in November 2013

Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway

scientific article published on 10 August 2020

Adjuvant Trastuzumab: Does Time Really Matter? ⬇️

scientific article published on April 26, 2013

Adjuvant chemotherapy for breast cancer: an update.

scientific article

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

scientific article published on 5 March 2012

Adjuvant therapy in early breast cancer

scientific article published on August 1, 1991

Adult multicenter trials using dexrazoxane to protect against cardiac toxicity

scientific article published on August 1, 1998

Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer

scientific article

Amenorrhea from Breast Cancer Therapy — Not a Matter of Dose

scientific article published on 01 December 2010

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

scientific article published on 27 November 2006

Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.

scientific article published on 27 February 2008

Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).

scientific article published on 11 April 2017

Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer

scientific article published on 3 January 2006

Aromatase inhibitors--a triumph of translational oncology

scientific article published in December 2005

Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

scientific article

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Bre

scientific article published on 01 November 2005

Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia

scientific article published on 24 January 2013

Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial.

scientific article

Autocrine and paracrine growth regulation of human breast cancer

scientific article published on 01 January 1986

Avastin withdrawal symptoms ⬇️

scientific article published on January 21, 2012

Baseline Characteristics, Treatment Patterns, and Outcomes in Patients with HER2-Positive Metastatic Breast Cancer by Hormone Receptor Status from SystHERs

scientific article published on 26 November 2019

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

article by Harry D. Bear et al published March 2013 in Obstetrical and Gynecological Survey

Bevacizumab added to neoadjuvant chemotherapy for breast cancer

scientific article

Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS metastases: the Road less Travelled

scientific article published on 08 January 2013

Bevacizumab and Heart Failure Risk in Patients With Breast Cancer: A Thorn in the Side?

scientific article published on 04 January 2011

Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer.

scientific article published on 20 October 2014

Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38.

scientific article

Building bridges to conquer cancer

scientific article published on 16 September 2013

CA 125 elevation in breast cancer: a case report and review of the literature.

scientific article published on March 2004

CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities

scientific article published on 19 June 2018

CLEOPATRA: a phase III evaluation of pertuzumab and trastuzumab for HER2-positive metastatic breast cancer

scientific article published on December 2010

Ca(2+)/calmodulin regulates Kvβ1.1-mediated inactivation of voltage-gated K(+) channels

scientific article published on 21 October 2015

Can we increase survival in breast cancer with innovative applications of conventional drugs?

scientific article published on 01 January 1994

Cardiac Protection in HER2-Targeted Treatment: How Should We Measure New Strategies?

scientific article published on 23 June 2016

Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines

scientific article published on 9 January 2016

Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study

scientific article published on 8 March 2013

Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancer

scientific article

Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.

scientific article published on January 2008

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

scientific article

Cardiovascular complications of breast cancer therapy

scientific article published on 01 April 2008

Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs

scientific article published on 28 December 2018

Changes in neurologic function tests may predict neurotoxicity caused by ixabepilone

scientific article

Chemotherapy: Updates and New Perspectives ⬇️

scientific article published on January 1, 2010

Circulating biomarkers of bevacizumab activity in patients with breast cancer

scientific article published on 21 November 2007

Clinical breast cancer research core

scientific article published on 01 January 1994

Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa

scientific article published on 22 April 2019

Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.

scientific article

Contralateral Breast Cancer: Where Does It All Begin?

scientific article published on 18 April 2005

Controversies in the treatment of cancer of the breast

scientific article

Corrigendum to "3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)" [Breast 31 (February 2017) 244-259].

scientific article published on 18 January 2017

Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial

scientific article published on 12 August 2013

Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer

scientific article published in February 2000

Detectable Inhibition of Heparin-Binding Growth Factor Activity in Sera From Patients Treated With Pentosan Polysulfate

scientific article published on 01 July 1993

Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR).

scientific article

Does CDKN2A loss predict palbociclib benefit?

scientific article

Drug discount program

scientific article

Ductal Carcinoma in Situ

scientific article published on 01 January 1992

Ductal carcinoma in situ, complexities and challenges.

scientific article published on June 2004

EARLY FLOWERING3 Regulates Flowering in Spring Barley by Mediating Gibberellin Production and FLOWERING LOCUS T Expression

scientific article published on 29 April 2014

Effect of docetaxel duration on clinical outcomes: exploratory analysis of CLEOPATRA, a phase III randomized controlled trial.

scientific article published on 3 November 2017

Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen: What Have We Learned?

scientific article published on 16 March 2016

Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II T

scientific article

Erratum to “NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors”.

scientific article published on 12 February 2014

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

scientific article

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer

scientific article published in April 2004

Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor

scientific article

Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer

scientific article published on 12 June 2012

Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray

scientific article published on February 2007

First, do no harm

scientific article published on 23 September 2008

Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.

scientific article

Focus on You: Cancer clinical trials perspectives

scientific article published on 16 September 2016

Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer

scientific article published on February 2010

Gene expression patterns and profile changes pre- and post-erlotinib treatment in patients with metastatic breast cancer

scientific article published on September 2005

Gene expression profile and angiogenic marker correlates with response to neoadjuvant bevacizumab followed by bevacizumab plus chemotherapy in breast cancer

scientific article

Genetic Analysis of Gibberellin Signal Transduction

scientific article published on 01 September 1996

Genomic profiling of breast cancer in African-American women using MammaPrint.

scientific article

HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens

scientific article published on 27 August 2016

Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer

scientific article published on 17 July 2013

Heparin-binding growth factor blockade with pentosan polysulfate

scientific article published on 01 November 1993

Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.

scientific article

Hormonal manipulation in the adjuvant treatment of breast cancer

scientific article published in January 1993

Hormone replacement therapy in women with a history of breast carcinoma

scientific article

IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer

scientific article published on 12 April 2019

Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies.

scientific article published on 17 May 2013

Improving Documentation of Pain Management at MedStar Washington Cancer Institute

scientific article published on 17 February 2015

In Situ or Localized Breast Cancer -- How Much Treatment Is Needed?

scientific article published on 01 June 1993

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab.

scientific article published on 2 January 2018

Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA.

scientific article

Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--initial experience.

scientific article published on September 2007

Influence of garlic (Allium sativum) on the pharmacokinetics of docetaxel

scientific article

Insights From the Cancer Center Business Summit: Preparing for the Future ⬇️

scientific article published on March 1, 2013

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

scientific article

Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial

scientific article

Ixabepilone for the treatment of solid tumors: a review of clinical data

scientific article

Ixabepilone: clinical role in metastatic breast cancer

scientific article published on 20 April 2011

Lactic Acidosis in Lymphoma: Prompt Resolution of Acidosis With Therapy Directed at the Lymphoma

scientific article published on 01 September 1988

Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial

scientific article published on 4 October 2013

Left Ventricular Ejection Fraction Monitoring Adherence Rates: Why So Low?

scientific article published on 01 August 2018

Liquid-chromatographic determination of erlotinib (OSI-774), an epidermal growth factor receptor tyrosine kinase inhibitor

scientific article published in October 2003

Locally Advanced and Inflammatory Breast Cancer

scientific article published on 01 February 2008

Locally advanced breast cancer

scientific article published on 01 December 1989

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Pa

scientific article published on 26 October 2017

Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.

scientific article published in February 2018

Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy

scientific article published in October 2004

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

scientific article

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer

scientific article

Luminal A Breast Cancer and Molecular Assays: A Review

article

Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial

scientific article

Meta-analysis: should it be more than the sum of its parts?

scientific article published on 23 November 2010

Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.

scientific article published on December 2002

Mitoxantrone, 5-fu, and leucovorin in breast cancer

scientific article published on 01 January 1994

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy

scientific article

NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors

scientific article

NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response

scientific article published on 05 May 2020

NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2 ⬇️

scientific article published on 10 December 2019

Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer

scientific article published on 01 July 1987

Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer

scientific article published on 19 May 2005

Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial

scientific article

Noninvasive breast cancer: Part 1. Ductal carcinoma in situ--incidence, presentation, guidelines to treatment

scientific article

Noninvasive breast cancer: Part 2. Lobular carcinoma in situ--incidence, presentation, guidelines to treatment.

scientific article

Novel agents: Clinical trial design ⬇️

scientific article published on October 1, 2001

Novel anticancer targets: revisiting ERBB2 and discovering ERBB3.

scientific article published on 18 June 2009

Ongoing adjuvant trials with trastuzumab in breast cancer.

scientific article

Oophorectomy in carriers of BRCA mutations

scientific article published in September 2002

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.

scientific article published on 14 June 2012

Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination

scientific article published on 19 August 2019

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

scientific article published on 14 February 2014

Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia.

scientific article published in October 2012

Pazopanib for the treatment of breast cancer

scientific article published on 10 January 2012

Peripheral neuropathy induced by microtubule-stabilizing agents.

scientific article

Pertuzumab : evolving therapeutic strategies in the management of HER2-overexpressing breast cancer

scientific article published on 27 March 2013

Pertuzumab for the treatment of breast cancer

scientific article

Pertuzumab for the treatment of breast cancer: a safety review

scientific article published on 16 March 2016

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer

scientific article

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.

scientific article

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

scientific article published on 12 March 2020

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

scientific article

Pertuzumab: increasing the options

scientific article published in March 2014

Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms

scientific article published on October 2002

Phase I trial of dasatinib and ixabepilone in patients with solid tumors

scientific article published on 06 March 2012

Phase I trial of pentosan polysulfate.

scientific article

Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer

scientific article

Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes

scientific article published on 02 July 2007

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer

scientific article

Phase II study of oral etoposide for patients with advanced breast cancer.

scientific article

Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer

scientific article published on 25 August 2006

Ppd-1 is a key regulator of inflorescence architecture and paired spikelet development in wheat

scientific article published on 26 January 2015

Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.

scientific article

Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer

scientific article published on 31 August 2020

Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study.

scientific article

Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age.

scientific article

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells

scientific article

Rationale and clinical trial design for evaluating gemcitabine as neoadjuvant and adjuvant therapy for breast cancer.

scientific article published on January 2004

Reimbursement for Solid Tumor Autologous Bone Marrow Transplantation Trials: A Strategy for Ensuring Continuation of a Promising Therapy

scientific article published on 01 January 1991

Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility

scientific article published on 01 December 1993

Reply to E.J. Moylan et al.

scientific article published on 13 January 2014

Reply to a. Avan et Al.

scientific article

Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014)

scientific article

Results of concomitantly administered chemoradiation for locally advanced noninflammatory breast cancer

scientific article published on 01 October 1994

Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapy.

scientific article

SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function.

scientific article

Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRA.

scientific article

Salvage treatment with intermediate-dose methotrexate and 5-fluorouracil in metastatic breast cancer

scientific article published in August 1988

Selection of therapy for stage III breast cancer

scientific article published on October 1990

Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epider

scientific article

Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer

scientific article published on 01 August 2019

Systemic therapy of locally advanced breast cancer: review and guidelines

scientific article published on January 1989

Take care of your neighborhood

scientific article published on 12 September 2017

Tamoxifen and contralateral breast cancer: the other side

scientific article published in July 2001

Tamoxifen and fluoxymesterone versus tamoxifen and danazol in metastatic breast cancer--a randomized study

scientific article published on September 1988

Tamoxifen for patients with estrogen receptor-negative breast cancer.

scientific article

Tamoxifen: the Long and Short of It

scientific article published on 01 November 1996

The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.

scientific article published on 18 November 2016

The Heart of the Matter

scientific article published on 30 July 2007

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer

scientific article

The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl

scientific article published on 12 January 2016

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review.

scientific article

The effect of systemic therapy on local-regional control in locally advanced breast cancer ⬇️

scientific article published on January 1, 1992

The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue

scientific article published on 01 February 1990

The impact of systemic therapy following ductal carcinoma in situ.

scientific article published on January 2010

The influence of a gene expression profile on breast cancer decisions

scientific article published in May 2009

The role of primary chemotherapy in early breast cancer.

scientific article published on February 1996

The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin.

scientific article published in January 1988

The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profiling

scientific article published on 27 November 2021

Therapy of patients with metastatic breast cancer with 5-fluorouracil, leucovorin and carboplatin.

scientific article

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

scientific article

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

scientific article (publication date: 20 October 2005)

Treatment and cost implications of pertuzumab

scientific article published on September 1, 2012

Treatment of HER2-positive metastatic breast cancer

scientific article published on May 2015

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA).

scientific article published on 16 October 2013

Treatment of patients with inflammatory breast cancer

scientific article

Treatment of stage III breast cancer. A panel discussion

scientific article published on July 1989

Tumor markers: should we or shouldn't we?

scientific article published on 01 May 2001

Twenty-five year results of the national cancer institute randomized breast conservation trial

scientific article published on 24 November 2011

Upholding the Affordable Care Act—implications for oncology

scientific article published on 07 August 2012

Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 30 November 2018

Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831

scientific article published on 07 September 2020

Video intervention increases participation of black breast cancer patients in therapeutic trials

scientific article published on 18 September 2017

Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study

scientific article published on 27 December 2014

What currently defines a breast center? Initial data from the national accreditation program for breast centers.

scientific article

p53, HER2 and tumor cell apoptosis correlate with clinical outcome after neoadjuvant bevacizumab plus chemotherapy in breast cancer

scientific article published on 9 March 2011

Paulina is supported by:

About Paulina

Help